# US 11,077,305 B2 · Identification of compromised components in a medical system > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 11,077,305 B2 - Document ID: US11077305B2 - Status: Granted - Kind: B2 - Application number: 15/699,873 - Filed: 2017-09-08 - Published: 2018-03-15 - Granted: 2021-08-03 - Earliest claimed: 2016-09-12 - Assignees: Medtronic, Inc. - Applicants: Medtronic, Inc. - Inventors: Jonathon E. Giftakis; Timothy J. Denison; Paul H. Stypulkowski; Scott R. Stanslaski; Robert S. Raike; Mae Eng; David E. Linde; Thomas Adamski - Web page: https://patentgrep.com/patent/US11077305B2 ## CPC - A61N 1/3614: {based on impedance measurement} - A61N 1/36142: {for improving safety} - A61N 1/0531: {Brain cortex electrodes} - A61N 1/0534: {Electrodes for deep brain stimulation} - A61N 1/36082: {Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease} - A61N 1/36185: {Selection of the electrode configuration} - A61N 2001/083: {Monitoring integrity of contacts, e.g. by impedance measurement} - A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B) ## Abstract In some examples of selecting a target therapy delivery site for treating a patient condition, a relatively high frequency electrical stimulation signal is delivered to at least two areas within a first region (e.g., an anterior nucleus of the thalamus) of a brain of a patient, and changes in brain activity (e.g., as indicated by bioelectrical brain signals) within a second region (e.g., a hippocampus) of the brain of the patient in response to the delivered stimulation are determined. The target therapy delivery site, an electrode combination, or both, may be selected based on the changes in brain activity. ## Claims ### Claim 1 A system, comprising: a sensor configured to sense a first signal at a first location of an anatomy of a patient, and one or more processors configured to associate a portion of the first signal with a second signal introduced at a second location of the anatomy of the patient and to determine whether a fault exists in the system based on one or more characteristics of the associated portion of the first signal, wherein the second signal is stimulation delivered to the second location; and wherein the sensor is configured to sense a response to the stimulation delivered at the second location and wherein the first location is a hippocampus of the brain and the second location is an anterior nucleus. ### Claim 2 (depends on 1) The system of claim 1, wherein the sensor is an electrode and the first signal is a local field potential signal and is sensed in the brain of the patient. ### Claim 3 (depends on 1) The system of claim 1, wherein the sensor is an electrode, and wherein the system comprises a lead carrying the electrode, and wherein the one or more processors are configured to determine whether the fault exists in the lead. ### Claim 4 (depends on 1) The system of claim 1, wherein the one or more processors are configured to detect that one of a lead or a lead extension of the implantable medical device system is associated with a low impedance pathway based on one or more characteristics of the associated portion of the first signal. ### Claim 5 (depends on 1) The system of claim 1, wherein the stimulation delivered at the second location comprises stimulation delivered at a frequency range of between 2-10 Hz. ### Claim 6 (depends on 1) The system of claim 1, wherein the sensor is an implantable electrode configured to sense a local field potential (LFP) signal. ### Claim 7 (depends on 6) The system of claim 6, wherein the one or more processors are configured to: determine whether the fault exists in the system based on one or more characteristics of the associated portion of the first signal by identifying an evoked response in the LFP signal and compare the identified evoked response in the sensed LFP signal to one or more baseline evoked response signals. ### Claim 8 (depends on 7) The system of claim 7, further comprising a memory to store the one or more baseline evoked response signals. ### Claim 9 (depends on 1) The system of claim 1, wherein the second signal comprises an artifact resulting from beating of the patient's heart, and wherein the one or more processors are configured to determine whether the fault exists in the system based on one or more characteristics of the associated portion of the first signal by detecting one or more characteristics of the artifact in the sensed first signal. ### Claim 10 (depends on 9) The system of claim 9, wherein the artifact is an ECG artifact and the sensed first signal is a brain signal. ### Claim 11 (depends on 1) The system of claim 1, wherein the one or more processors are further configured to: receive one or more values indicative of impedance associated with one or more components of the implantable medical device system; and determine whether any of the received values are out of range; and if any of the received values are out of range: initiate sensing, via the sensor, of the first signal at the first location of the anatomy of a patient; associate the portion of the first signal with a second signal introduced at a second location of the anatomy of the patient; and determine whether the fault exists in the system based on one or more characteristics of the associated portion of the first signal. ### Claim 12 A system, comprising: a sensor configured to sense a first signal at a first location of an anatomy of a patient and one or more processors configured to associate a portion of the first signal with a second signal introduced at a second location of the anatomy of the patient and to determine whether a fault exists in the system based on one or more characteristics of the associated portion of the first signal, wherein the second signal is stimulation delivered to the second location, wherein the sensor is configured to sense a response to the stimulation delivered at the second location, and wherein the first location is a location within a first hemisphere of the brain and the second location is a location within a second hemisphere of the brain. ### Claim 13 A system, comprising: a sensor configured to sense a first signal at a first location of an anatomy of a patient; and one or more processors configured to associate a portion of the first signal with a second signal introduced at a second location of the anatomy of the patient and to determine whether a fault exists in the system based on one or more characteristics of the associated portion of the first signal, wherein the second signal is stimulation delivered to the second location, wherein the sensor is configured to sense a response to the stimulation delivered at the second location, and wherein the stimulation delivered at the second location comprises stimulation delivered at a frequency range of between 2-10 Hz. ### Claim 14 A system, comprising: a sensor configured to sense a first signal at a first location of an anatomy of a patient; and one or more processors configured to associate a portion of the first signal with a second signal introduced at a second location of the anatomy of the patient and to determine whether a fault exists in the system based on one or more characteristics of the associated portion of the first signal, wherein the second signal is stimulation delivered to the second location, wherein the sensor is configured to sense a response to the stimulation delivered at the second location, wherein the sensor is an implantable electrode configured to sense a local field potential (LFP) signal, and wherein the one or more processors are configured to: determine whether the fault exists in the system based on one or more characteristics of the associated portion of the first signal by identifying an evoked response in the LFP signal and compare the identified evoked response in the sensed LFP signal to one or more baseline evoked response signals. ### Claim 15 A system, comprising: a sensor configured to sense a first signal at a first location of an anatomy of a patient; and one or more processors configured to associate a portion of the first signal with a second signal introduced at a second location of the anatomy of the patient and to determine whether a fault exists in the system based on one or more characteristics of the associated portion of the first signal, wherein the second signal comprises an artifact resulting from beating of the patient's heart, and wherein the one or more processors are configured to determine whether the fault exists in the system based on one or more characteristics of the associated portion of the first signal by detecting one or more characteristics of the artifact in the sensed first signal. ### Claim 16 A system, comprising: a sensor configured to sense a first signal at a first location of an anatomy of a patient; and one or more processors configured to associate a portion of the first signal with a second signal introduced at a second location of the anatomy of the patient and to determine whether a fault exists in the system based on one or more characteristics of the associated portion of the first signal, wherein the one or more processors are further configured to: receive one or more values indicative of impedance associated with one or more components of the implantable medical device system; and determine whether any of the received values are out of range; and if any of the received values are out of range: initiate sensing, via the sensor, of the first signal at the first location of the anatomy of a patient; associate the portion of the first signal with a second signal introduced at a second location of the anatomy of the patient; and determine whether the fault exists in the system based on one or more characteristics of the associated portion of the first signal. ### Claim 17 A method of detecting a fault in an implantable medical device system, comprising: sensing a first signal via an electrode at a first location of an anatomy of a patient, at one or more processors, associating a portion of the first signal with a second signal introduced at a second location of the anatomy of the patient; and at the one or more processors, determining whether a fault exists in the system based on one or more characteristics of the associated portion of the first signal, wherein one or more of associating a portion of the first signal with the second signal introduced at the second location in the anatomy of the patient and determining whether the fault exists in the system are performed by one or more processors, wherein the second signal is stimulation delivered to the second location; and wherein sensing, via an electrode at a first location of an anatomy of a patient, comprises sensing a response to the stimulation delivered at the second location and wherein the first location is a hippocampus of the brain and the second location is an anterior nucleus. ### Claim 18 (depends on 17) The method of claim 17, wherein the first signal is a local field potential signal. ### Claim 19 (depends on 17) The method of claim 17, wherein the first signal is a signal sensed from the brain of a patient. ### Claim 20 (depends on 17) The method of claim 17, wherein the fault is a fault in one or more of a lead or a lead extension of the implantable medical device system. ### Claim 21 (depends on 17) The method of claim 17, wherein determining whether a fault exists in the system based on one or more characteristics of the associated portion of the first signal comprises detecting that a lead of the implantable medical device system has a short circuit. ### Claim 22 (depends on 17) The method of claim 17, wherein the stimulation delivered at the second location comprises stimulation delivered at a frequency range of between 2-10 Hz. ### Claim 23 (depends on 17) The method of claim 17, wherein sensing a first signal via an electrode at a first location of an anatomy of the patient comprises sensing a local field potential (LFP) signal via the implantable electrode at the first location of the anatomy of the patient. ### Claim 24 (depends on 23) The method of claim 23, wherein determining whether a fault exists in the system based on one or more characteristics of the associated portion of the first signal comprises identifying an evoked response in the LFP signal and further comprising comparing the identified evoked response in the sensed LFP signal to one or more baseline evoked response signals. ### Claim 25 (depends on 24) The method of claim 24, wherein the one or more baseline evoked response signals are representative of evoked response signals that are obtained when it is known that a fault is not present in the system. ### Claim 26 (depends on 17) The method of claim 17, wherein the first location is a location within a first hemisphere of the brain and the second location is a location within a second hemisphere of the brain. ### Claim 27 (depends on 17) The method of claim 17, wherein the second signal comprises an artifact resulting from activity of the patient's heart, and wherein determining whether a fault exists in the system based on one or more characteristics of the associated portion of the first signal comprises detecting one or more characteristics of the artifact in the sensed first signal. ### Claim 28 (depends on 27) The method of claim 27, wherein the artifact is an ECG artifact and the sensed first signal is a brain signal. ### Claim 29 (depends on 17) The method of claim 17, wherein the second signal comprises a movement artifact and wherein determining whether a fault exists in the system based on one or more characteristics of the associated portion of the first signal comprises detecting one or more characteristics of the movement artifact in the sensed first signal. ### Claim 30 (depends on 29) The method of claim 29, wherein the first signal is a brain signal. ### Claim 31 (depends on 17) The method of claim 17, further comprising: determining whether one or more impedance values within the implantable medical device system are out of range; and if one or more impedance values within the implantable medical device system are out of range, initiating the sensing of the first signal via the electrode at the first location of the anatomy of a patient, the associating of the portion of the first signal with the second signal introduced at the second location of the anatomy of the patient and the determining whether the fault exists in the system based on one or more characteristics of the associated portion of the first signal.